Oncobiologics, Inc. (OTLK) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.83 per share a year ago.

Clene Inc. (CLNN) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to a loss of $1.06 per share a year ago.

Evaluate the expected performance of Home Depot (HD) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Douglas Dynamics (PLOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

VYNE Therapeutics Inc. (VYNE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.22 per share a year ago.

Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.

Evaluate the expected performance of Premier (PINC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Besides Wall Street's top-and-bottom-line estimates for Jack Henry (JKHY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

Get a deeper insight into the potential performance of Alcon (ALC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Get a deeper insight into the potential performance of Toll Brothers (TOL) for the quarter ended July 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Evaluate the expected performance of Keysight (KEYS) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Hyperion DeFi becomes the first institution to stake HYPE through Kinetiq's compliant liquid staking infrastructure Hyperion DeFi becomes the first institution to stake HYPE through Kinetiq's compliant liquid staking infrastructure

JPMorgan analyst Nick Lai cut his rating on Li Auto stock to Hold from Buy. He is worried about slowing demand.

CompoSecure has rebounded strongly after a previous dip earlier this year, and is now trading above its prior highs, prompting a reassessment of its upside potential. Analysts remain bullish, with multiple Buy ratings and raised price targets following Q2 results. The spin-off of Resolute Holdings in the first quarter of this year has boosted profit margins and adjusted EBITDA significantly at CompoSecure.

Lifeward (LFWD) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.5 per share a year ago.

MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $0.76 per share a year ago.

ByPeter Cohan,

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SelectQuote, Inc. ("SelectQuote" or …

Mark Bowser (former CFO/EVP of Cox Automotive) and Neil Glat (former President of the New York Jets, Chairman of the Board at Evolv Technology and board member at Fubo) to Stand for Election to the Company's Board of Directors Mark Bowser (former CFO/EVP of Cox Automotive) and Neil Glat (former President of the New York Jets, Chairman of the Board at Evolv Technology and board member at Fubo) to Stand for Election to the Company's Board of Directors

Any analysis of Palantir Technologies Inc. NASDAQ: PLTR inevitably returns to valuation. Investors are told that fundamentals matter, and then they look at what's going on with PLTR stock.